Signals Blog
Menu

Stifling Science?

  On June 18, 2014, I walked into the enormous, blue lit plenary hall of the Vancouver Convention Centre excited to hear Canada’s own Janet Rossant give the opening remarks for ISSCR’s Presidential Symposium. I glanced up at the information screens and read, to my...

Right Turn: Stem Cell Diabetes Treatment Looking Sweet

. It’s nice to end the week on a happy note. For a company like CCRM that commercializes regenerative medicine products and therapies, the news that ViaCyte, a company based in San Diego, California, has applied to the FDA to start clinical trials for its Type 1...

Highlights from The Business of Regenerative Medicine Course

. The Centre for Commercialization of Regenerative Medicine (CCRM) just finished hosting the 7th annual Business of Regenerative Medicine course here in Toronto, which saw many notable figures in the space come to weigh-in on a number of critical issues relevant to...